FORMULATION AND ANALYTICAL METHOD DEVELOPMENT OF ATORVASTATIN–BERBERINE SOLID DISPERSION TABLETS USING AN ANALYTICAL QUALITY BY DESIGN-ORIENTED APPROACH
Atorvastatin is an effective lipid-lowering agent. However, its poor aqueous solubility may limit dissolution and consequently affect its oral bioavailability. Berberine is a naturally occurring alkaloid with several pharmacological activities; however, its pharmaceutical development is also challenged by limited aqueous solubility and low oral bioavailability. The present study was undertaken to formulate an atorvastatin-berberine solid dispersion using polyvinylpyrrolidone K30 (PVP K30) as a hydrophilic carrier and to develop the resulting solid dispersion into a tablet dosage form. The solid dispersion was prepared using an atorvastatin:berberine:PVP K30 ratio of 1:1:5. The prepared tablets were evaluated for their physical characteristics and dissolution performance. In addition, a UV-visible spectrophotometric analytical procedure was developed using an Analytical Quality by Design oriented approach, with wavelength, solvent and scanning speed investigated as analytical variables. The analytical procedure was further evaluated for linearity, precision, accuracy, specificity and sensitivity. The prepared tablets showed a disintegration time of 15 mins, hardness of 5.1 kg/cm2 and friability of 0.60%. At 45 min, the solid dispersion formulation showed 93.45% drug release, compared with 75.49% for the physical mixture and 98.63% for the marketed formulation. The analytical procedure demonstrated a linear response over the investigated concentration range of 2-12 μg/mL, with satisfactory precision and recovery. Overall, the study demonstrated the potential of PVP K30-based solid dispersion for improving the dissolution performance of the atorvastatin-berberine formulation and provides a systematic approach for analytical method development.
Authors
- Sachin W. Lohe
- Anshuman Borkar
- Ms. K. N. Dhurvey (ORCID: https://orcid.org/0009-0008-0184-8122)
- Kumudini Dhurve
- Pranjali Raut
- Gaurav Badwaik
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-21
- DOI
- https://doi.org/10.5281/zenodo.24415728
- Primary Topic
- Drug Solubulity and Delivery Systems
- Type
- article
- Field-Weighted Citation Impact
- 0.00